Eli Lilly and Company's Erbitux Fails In European Colon Cancer Study
MILAN, Oct 10 (Reuters) - Two small European studies cast doubt on the benefits of two key bowel cancer drugs on Sunday, puzzling experts at Europe's biggest cancer meeting in Milan.